The memantine market has witnessed steady growth in the past few years owing to the growing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease and other dementias. Memantine is a non-competitive NMDA receptor antagonist used for the treatment of moderate to severe Alzheimer's disease. It is an oral medication that gradually controls the activity of chemical messengers in the brain and helps minimize or slow down symptoms. The growing geriatric population which is more prone to such neurological conditions and rise in R&D activities focusing on developing novel therapeutics for previously untreatable disorders are the key factors driving the growth of the memantine market.
The Global Memantine Market is estimated to be valued at US$ 921.6 Mn in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Memantine Market Demand are Aggregate Industries Ltd., Anglo American Plc, Atlas Roofing Corporation, BP Plc, Cemex, Chevron Corporation, Exxon Mobil Corporation, Imperial Oil Limited, Owens Corning, Petroleos de Venezuela S.A, Royal Dutch Shell plc, Shell International, Total SA, United Refining Inc. Major players in the memantine market are focusing on strategies such as new product launches, collaborations and acquisitions to strengthen their market position and expand their geographic footprint. The increasing R&D investments and growing awareness about early diagnosis provide lucrative growth opportunities for key players in the memantine market. The rising burden of neurological diseases worldwide has encouraged major memantine market players to expand their business operations across different geographies with a focus on developing and emerging economies. Market Drivers
Rising Geriatric Population: The risk of neurological disorders significantly increases with age. As per WHO, the global population aged 60 years and older is expected to double from 12% to 22% between 2015 and 2050. This growing geriatric demographic is driving the demand for memantine used for the treatment of age-related neurodegenerative conditions. Increasing R&D Investments: Significant investments are being made by government and private organizations to support research focusing on developing novel treatment options for previously untreatable neurological diseases. Several clinical trials are being conducted to evaluate the efficacy of memantine for wider applications which is propelling the market growth. Market Restraints
Side Effects: Though generally well-tolerated, memantine use has been associated with side effects like dizziness, headache and constipation which discourages some patients from long-term compliance to the therapy. Patent Expiry: Patent protection for memantine is expected to expire in coming years, enabling the entry of generic versions in the market. This is anticipated to intensify competition and may negatively impact the revenue stream of established brands. the global memantine market is expected to demonstrate positive growth over the forecast period supported by the rising prevalence of Alzheimer's disease and other forms of dementia worldwide coupled with increasing R&D investments.
Segment Analysis The Memantine Market Size and Trends is dominated by the Alzheimer's disease segment. Over 60% of memantine is used for treating moderate to severe Alzheimer's disease. This is because Alzheimer's disease is the most common form of dementia affecting over 5 million Americans annually and there are no significant disease-modifying treatments available for it apart from drugs like memantine which provide symptomatic benefits. The mild to moderate vascular dementia segment is the second largest segment for memantine. This is because vascular dementia accounts for almost 20% of all cases of dementia globally and memantine helps improve cognitive functions in such patients. Global Analysis The North American region accounts for over 40% of the memantine market share globally. This is due to the rising geriatric population and growing prevalence of Alzheimer's disease in countries like the United States. It is estimated that by 2050, around 16 million Americans will be suffering from Alzheimer's disease. The presence of major players as well as availability of reimbursements for memantine therapy drive the market in North America. Europe accounts for the second largest share due to increasing government initiatives to enhance treatment of neurological disorders. However, the Asia Pacific region is anticipated to witness the highest growth during the forecast period owing to rapidly growing geriatric population, rising awareness about dementia, and increasing healthcare spending in emerging countries such as China and India.
Explore More Related Article On- Lactulose Market
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.
Click here to know more on Non-Small Cell Lung Cancer pipeline NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many othersKey Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.Market DriverMarket Barrier The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.Detailed Non-Small Cell Lung Cancer market size by therapies, covering the United States, EU5 and Japan from 2017-2030.Reimbursement scenario and Key Opinion Leader Views Table of ContentsKey InsightsExecutive Summary of NSCLCSWOT Analysis of NSCLCNSCLC: Market Overview at a Glance4.1.
Total Market size of NSCLC in JapanALK-Mutation—Market Size21.1.
Report MethodologyDelveInsight CapabilitiesDisclaimerAbout DelveInsight Request a Webex Demo to get a walk-through of the report: https://www.delveinsight.com/sample-request/non-small-cell-lung-cancer-marketRelated Reports:Non-Small Cell Lung Cancer Epidemiology Forecast to 2030Non-Small Cell Lung Cancer Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020Non-Small Cell Lung Cancer Pipeline Insights, 2020About DelveInsightDelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment.
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Want to develop Music Streaming Mobile App l?
Explore key features, market size, required team & development cost for Music Streaming application development.
Oct 01, 2019 (The Expresswire) -- Laminar Flow Cabinets Market study throws bright on the Consumer behavior and retail (POP) factor for instruments industry.
Global “Laminar Flow Cabinets Market” 2019 provides whole analysis of Key market segments and sub-segments Evolving market trends and dynamics, changing supply and demand scenarios, Quantifying market opportunities through market sizing and market forecasting Tracking current trends/opportunities/challenges.
Get a sample copy of the report :- https://www.absolutereports.com/enquiry/request-sample/14108266
with the slowdown in world economic growth, the Laminar Flow Cabinets industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Laminar Flow Cabinets market size to maintain the average annual growth rate of 0.0364160526935 from 240.0 million $ in 2014 to 287.0 million $ in 2018, BisReport analysts believe that in the next few years, Laminar Flow Cabinets market size will be further expanded, we expect that by 2023, The market size of the Laminar Flow Cabinets will reach 340.0 million $.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better.
This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
